I wrote previously (10th Dec) about Israeli personalized cancer biotech Ayala and its partnership with Bristol-Myers Squibb. One of the results of this tie-up is AL101 – a new treatment for metastatic Adenoid Cystic Carcinoma (ACC), which could also treat triple-negative breast cancer.
Treatment for Adnoid Cystic Carcinoma
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.